The Omega 3 Prescription Drugs Global Market Report 2023 by The Business Research Company, provides omega 3 prescription drugs market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.
Learn More On The Omega 3 Prescription Drugs Market:
https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report
According to The Business Research Company’s Omega 3 Prescription Drugs Global Market Report 2023, the global omega 3 prescription drugs market size is expected to grow from $1.37 billion in 2022 to $1.49 billion in 2023 at a compound annual growth rate (CAGR) of 8.74%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the omega 3 prescription drugs market is expected to reach $2.09 billion in 2027 at a CAGR of 8.84%.
Rising cases of cardiovascular diseases (CVDs) are expected to contribute to the growth of the omega-3 prescription drug market. Increased blood triglyceride levels (a fatty-like substance) are linked to a higher risk of cardiovascular disorders, and omega-3 supplements aid in regulating and lowering triglyceride levels.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=8091&type=smp
The omega 3 prescription drugs market is segmented:
1) By Drug Type: Vascepa, Lovaza, Other Type
2) By Application Type: Hypertriglyceridemia, Other Application Type
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
New product innovations have emerged as a key trend gaining popularity in the omega-3 prescription drug market. Major companies operating in the manufacturing of omega-3 drugs are focused on developing new product innovations to strengthen their position in the market. For instance, in October 2022, the European Commission gave the green light to plant-based omega-3 products from DSM for fish and animal substitutes throughout the EU. DSM claims that the product enhances plant-based foods’ nutritional profile and enables the development of fish products based on animals that will be similar to current fish products. This omega 3 supplement can be used to enhance the nutritional content of goods without having an adverse effect on the marine ecosystem.
The omega 3 prescription drugs market report table of contents includes:
.
.
.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The regulatory compliance management software global market report 2024from The Business Research Company provides comprehensive…
The programming language global market report 2024from The Business Research Company provides comprehensive market statistics,…
The oral transmucosal drugs global market report 2024from The Business Research Company provides comprehensive market…
The morphine drugs global market report 2024from The Business Research Company provides comprehensive market statistics,…
Market Size - The melatonin supplements market size has grown rapidly in recent years. It will…
Market Size - The specimen validity testing market size has grown strongly in recent years. It…